Pulmonary surfactant proteins.
Lacaze-Masmonteil
T
T
Faculté de Médecine, Cochin-Post Royal, Paris, France.
D000818:Animals; D055592:Biophysical Phenomena; D001703:Biophysics; D002199:Capillary Permeability / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D000242:Cyclic AMP / Q000502:physiology; D005325:Fetal Organ Maturity; D015870:Gene Expression; D005938:Glucocorticoids / Q000502:physiology; D006023:Glycoproteins / Q000737:chemistry* / Q000235:genetics / Q000502:physiology; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D008168:Lung / Q000166:cytology* / Q000196:embryology*; D016676:Macrophages, Alveolar / Q000187:drug effects; D051379:Mice; D008970:Molecular Weight; D010587:Phagocytosis / Q000187:drug effects; D010743:Phospholipids / Q000737:chemistry / Q000378:metabolism; D014176:Protein Biosynthesis; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D011510:Proteolipids / Q000737:chemistry* / Q000235:genetics / Q000502:physiology; D037663:Pulmonary Surfactant-Associated Protein D; D037661:Pulmonary Surfactant-Associated Proteins; D011663:Pulmonary Surfactants / Q000032:analysis* / Q000737:chemistry* / Q000235:genetics / Q000502:physiology / Q000627:therapeutic use; D014158:Transcription, Genetic; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D005938:Glucocorticoids; D006023:Glycoproteins; D010743:Phospholipids; D011510:Proteolipids; D037663:Pulmonary Surfactant-Associated Protein D; D037661:Pulmonary Surfactant-Associated Proteins; D011663:Pulmonary Surfactants; D014409:Tumor Necrosis Factor-alpha; D000242:Cyclic AMP